سعر تريتاس Tritace‏ 1.25مجم 14 قرص 2026

Tritace (ramipril) 1.25 mg tablets, pack of 14, Sanofi (Egypt).

• Common: headache, dizziness, hyperkalaemia, non-productive cough, bronchitis, sinusitis, dyspnoea, hypotension, orthostatic hypotension, syncope, gastrointestinal inflammation, digestive disturbances, diarrhoea, nausea, vomiting, rash, muscle spasms, myalgia, chest pain, fatigue.International label, same formulation · electronic medicines compendium (emc)

• Hypersensitivity to ramipril, excipients or any other ACE inhibitor; history of angioedema (hereditary, idiopathic or previous with ACE inhibitors or ARBs).International label, same formulation · electronic medicines compendium (emc)
• Concomitant sacubitril/valsartan; extracorporeal treatments leading to contact of blood with negatively charged surfaces.International label, same formulation · electronic medicines compendium (emc)
• Significant bilateral renal artery stenosis or renal artery stenosis in a single functioning kidney; hypotensive or haemodynamically unstable states.International label, same formulation · electronic medicines compendium (emc)

• Risk of symptomatic hypotension in patients with strongly activated renin-angiotensin-aldosterone system (e.g. diuretics, salt or volume depletion, heart failure); correct dehydration before treatment; caution at surgery/anaesthesia.International label, same formulation · electronic medicines compendium (emc)
• Angioedema, including intestinal angioedema, may occur; discontinue immediately. Increased risk with mTOR inhibitors, vildagliptin or racecadotril.International label, same formulation · electronic medicines compendium (emc)
• Hyperkalaemia, hyponatraemia (SIADH) and neutropenia/agranulocytosis may occur; monitor serum potassium, sodium and white blood cell count, and renal function.International label, same formulation · electronic medicines compendium (emc)

• Sacubitril/valsartanContraindicated (angioedema); do not start ramipril until 36 hours after the last sacubitril/valsartan dose.electronic medicines compendium (emc)
• Potassium salts, heparin, potassium-retaining diuretics, trimethoprim/co-trimoxazole, tacrolimus, ciclosporinHyperkalaemia may occur; monitor serum potassium closely.electronic medicines compendium (emc)
• LithiumLithium excretion may be reduced and toxicity increased; monitor lithium levels.electronic medicines compendium (emc)

• Not recommended during the first trimester and contraindicated in the second and third trimesters; when pregnancy is diagnosed, stop treatment immediately and start alternative therapy if appropriate.International label, same formulation · electronic medicines compendium (emc)
• Not recommended; alternative treatments with better established safety profiles during breastfeeding are preferable, especially for newborn or preterm infants.International label, same formulation · electronic medicines compendium (emc)

English text not available for this section.